Volume | 550,650 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 16.7309 | Mínimo Máximo |
|||||
Minimo del Dia | 15.80 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Agenus Inc | AGEN | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
16.45 | 15.80 | 16.7309 | 16.60 | 16.56 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
8,043 | 550,650 | US$ 16.34 | US$ 8,996,040 | - | 4.775 - 42.60 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:59:59 | 7 | US$ 16.75 | USD |
Información Financiera Agenus Inc AGEN
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
6.96B | 418.92M | - | 156.87M | -245.97M | -0.59 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Agenus Inc AGEN
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
04/6/2024 | 06:30 | Business Wire | Agenus Announces Virtual Annual Shareholders Meeting |
30/5/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
24/5/2024 | 16:00 | Business Wire | Agenus Reports Inducement Grants Under Nasdaq Listing Rule.. |
23/5/2024 | 16:10 | Business Wire | Breakthrough Data on Botensilimab/Balstilimab in MSS CRC.. |
23/5/2024 | 06:30 | Business Wire | Agenus to Participate in Goldman Sachs 45th Annual Global.. |
16/5/2024 | 06:30 | Business Wire | FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss.. |
07/5/2024 | 06:40 | Business Wire | Agenus Reports First Quarter 2024 Results |
07/5/2024 | 06:39 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 06:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
07/5/2024 | 06:31 | Edgar (US Regulatory) | Form 8-K - Current report |
01/5/2024 | 06:30 | Business Wire | Agenus Regains Compliance with Nasdaq Minimum Bid Price.. |
24/4/2024 | 09:00 | Business Wire | Botensilimab/Balstilimab Data in MSS CRC Selected for the.. |
Histórico de Datos AGEN
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.13 | 19.688 | 14.72 | 16.98 | 867,203 | 1.07 | 7.07% |
1 Month | 12.06 | 19.688 | 10.05 | 14.06 | 632,493 | 4.14 | 34.33% |
3 Months | 12.104 | 19.688 | 4.775 | 10.39 | 3,709,241 | 4.10 | 33.84% |
6 Months | 15.60 | 19.688 | 4.775 | 13.35 | 8,061,465 | 0.60 | 3.85% |
1 Year | 38.40 | 42.60 | 4.775 | 17.78 | 6,974,806 | -22.20 | -57.81% |
3 Years | 80.60 | 135.80 | 4.775 | 40.62 | 5,284,822 | -64.40 | -79.90% |
5 Years | 53.60 | 135.80 | 4.775 | 47.99 | 4,154,915 | -37.40 | -69.78% |